Additional information on COVID-19 vaccines and A-T can be found here.

Hi A-T Parents,

As promised, we are getting together for a discussion about COVID-19 and vaccines.

The A-T Children’s Project has planned a special webinar that I will be moderating:

COVID-19 Vaccines and Ataxia-Telangiectasia – a conversation with:

  • Howard Lederman, MD, PhD – Pediatric Immunologist and Director of the A-T Clinical Center at Johns Hopkins Children’s Center
  • Brad Margus – Founder of the A-T Children’s Project and father of two sons with A-T

Monday, January 11 at 8:00 PM Eastern (5:00 PM Pacific)

Watch the replay on our YouTube channel:

The webinar will be recorded. Everyone who registers will receive a link to the recording whether or not you attend live.

Dr. Lederman will not be able to offer individual advice, but please do let me know if you have any general questions by emailing me at

We hope this helps!

Keep safe,


Jennifer Thornton, Executive Director

Related News

May 21 @ 5:54 am

Shining a Light on A-T at the IlluminATion Ball

The A-TCP is hosting IlluminATion: A BioPharma Leadership Ball on May 11 in Boston to shine a light

May 21 @ 5:54 am

NEAT Study – Phase 3 Clinical Trial of EryDex, a Low-Dose Steroid

Quince Therapeutics is advancing a phase 3 clinical trial to evaluate EryDex, a potential new treatment for ataxia-telangiectasia

May 21 @ 5:54 am

Measles Prevention in A-T: Recommendations from Dr. Lederman

Dr. Lederman of the A-T Clinical Center provides recommendations to keep people with A-T from catching measles.

May 21 @ 5:54 am

Looking Forward to Research Advances in 2024

As 2023 is wrapping up, we want to thank all of you who support the A-T Children’s Project